These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 25809691)

  • 1. Bayesian regression discontinuity designs: incorporating clinical knowledge in the causal analysis of primary care data.
    Geneletti S; O'Keeffe AG; Sharples LD; Richardson S; Baio G
    Stat Med; 2015 Jul; 34(15):2334-52. PubMed ID: 25809691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dirichlet process mixture models for regression discontinuity designs.
    Ricciardi F; Liverani S; Baio G
    Stat Methods Med Res; 2023 Jan; 32(1):55-70. PubMed ID: 36366738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regression Discontinuity for Causal Effect Estimation in Epidemiology.
    Oldenburg CE; Moscoe E; Bärnighausen T
    Curr Epidemiol Rep; 2016; 3():233-241. PubMed ID: 27547695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regression Discontinuity Design: Simulation and Application in Two Cardiovascular Trials with Continuous Outcomes.
    van Leeuwen N; Lingsma HF; de Craen AJ; Nieboer D; Mooijaart SP; Richard E; Steyerberg EW
    Epidemiology; 2016 Jul; 27(4):503-11. PubMed ID: 27031038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Approaches to the Estimation of the Local Average Treatment Effect in a Regression Discontinuity Design.
    O'Keeffe AG; Baio G
    Scand Stat Theory Appl; 2016 Dec; 43(4):978-995. PubMed ID: 27867250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regression discontinuity design to evaluate the effect of statins on myocardial infarction in electronic health records.
    Odden MC; Zhang A; Jawadekar N; Tan A; Moran AE; Glymour MM; Brayne C; Zeki Al Hazzouri A; Calonico S
    Eur J Epidemiol; 2023 Apr; 38(4):393-402. PubMed ID: 36935439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Graphical Models for Quasi-experimental Designs.
    Steiner PM; Kim Y; Hall CE; Su D
    Sociol Methods Res; 2017 Mar; 46(2):155-188. PubMed ID: 30174355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regression discontinuity was a valid design for dichotomous outcomes in three randomized trials.
    van Leeuwen N; Lingsma HF; Mooijaart SP; Nieboer D; Trompet S; Steyerberg EW
    J Clin Epidemiol; 2018 Jun; 98():70-79. PubMed ID: 29486280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review and economic evaluation of statins for the prevention of coronary events.
    Ward S; Lloyd Jones M; Pandor A; Holmes M; Ara R; Ryan A; Yeo W; Payne N
    Health Technol Assess; 2007 Apr; 11(14):1-160, iii-iv. PubMed ID: 17408535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cohort study investigating the relationship between cholesterol, cardiovascular risk score and the prescribing of statins in UK primary care: study protocol.
    Finnikin S; Ryan R; Marshall T
    BMJ Open; 2016 Nov; 6(11):e013120. PubMed ID: 27856481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Statins in Current Guidelines.
    Rached F; Santos RD
    Curr Atheroscler Rep; 2020 Aug; 22(9):50. PubMed ID: 32770357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tackling statin intolerance with n-of-1 trials (TaSINI) in primary care: protocol for a feasibility randomised trial to increase statin adherence.
    Tudor K; Brooks J; Howick J; Fox R; Aveyard P
    BMJ Open; 2020 Feb; 10(2):e033070. PubMed ID: 32051312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The causes and effects of socio-demographic exclusions from clinical trials.
    Bartlett C; Doyal L; Ebrahim S; Davey P; Bachmann M; Egger M; Dieppe P
    Health Technol Assess; 2005 Oct; 9(38):iii-iv, ix-x, 1-152. PubMed ID: 16181564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The regression discontinuity design showed to be a valid alternative to a randomized controlled trial for estimating treatment effects.
    Maas IL; Nolte S; Walter OB; Berger T; Hautzinger M; Hohagen F; Lutz W; Meyer B; Schröder J; Späth C; Klein JP; Moritz S; Rose M
    J Clin Epidemiol; 2017 Feb; 82():94-102. PubMed ID: 27865902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regression discontinuity designs in epidemiology: causal inference without randomized trials.
    Bor J; Moscoe E; Mutevedzi P; Newell ML; Bärnighausen T
    Epidemiology; 2014 Sep; 25(5):729-37. PubMed ID: 25061922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression discontinuity designs are underutilized in medicine, epidemiology, and public health: a review of current and best practice.
    Moscoe E; Bor J; Bärnighausen T
    J Clin Epidemiol; 2015 Feb; 68(2):122-33. PubMed ID: 25579639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probing the Effective Treatment Thresholds for Alteplase in Acute Ischemic Stroke With Regression Discontinuity Designs.
    Naidech AM; Lawlor PN; Xu H; Fonarow GC; Xian Y; Smith EE; Schwamm L; Matsouaka R; Prabhakaran S; Marinescu I; Kording KP
    Front Neurol; 2020; 11():961. PubMed ID: 32982952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
    Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF
    Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An electronic health record based model predicts statin adherence, LDL cholesterol, and cardiovascular disease in the United States Military Health System.
    Lucas JE; Bazemore TC; Alo C; Monahan PB; Voora D
    PLoS One; 2017; 12(11):e0187809. PubMed ID: 29155848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bayesian multivariate skew meta-regression models for individual patient data.
    Ibrahim JG; Kim S; Chen MH; Shah AK; Lin J
    Stat Methods Med Res; 2019; 28(10-11):3415-3436. PubMed ID: 30309294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.